Beta‐amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study

Authors:

Abstract
Introduction: The present study investigated the relationship between beta‐amyloid (Aβ) and cognition in a late middle‐aged cohort at risk for Alzheimer's disease (AD).Methods: One eighty‐four participants (mean age = 60; 72% parental history of AD) completed a [C‐11]Pittsburgh compound B positron emission tomography scan and serial cognitive evaluations. A global measure of Aβ burden was calculated, and composite scores assessing learning, delayed memory, and executive functioning were computed.Results: Higher Aβ was associated with classification of psychometric mild cognitive impairment (MCI) at follow‐up (P < .01). Linear mixed effects regression results indicated higher Aβ was associated with greater rates of decline in delayed memory (P < .01) and executive functioning (P < .05). Apolipoprotein E (APOE) ε4 status moderated the relationship between Aβ and cognitive trajectories (P values <.01).Discussion: In individuals at risk for AD, greater Aβ in late middle age is associated with increased likelihood of MCI at follow‐up and steeper rates of cognitive decline.
Funding Information
  • National Center for Advancing Translational Sciences (UL1TR00427)
  • National Institute on Aging (T32 AG000213)